Study of Labetuzumab Govitecan in Participants With Metastatic Colorectal Cancer
Clinical trial NCT01605318 · TERMINATED
Trial details
- NCT number
- NCT01605318
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-12
- Primary completion
- 2017-01-03
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.